Sign for Notice Everyday    Sign Up| Sign In| Link| English|

Our Sponsors

    Receive Latest News

    Feedburner
    Share Us


    Live Webinar Understanding and Implementing a Quality by Design Program

    View: 152

    Website https://worldcomplianceseminars.com/webinardetails/345 | Want to Edit it Edit Freely

    Category

    Deadline: April 30, 2018 | Date: May 02, 2018

    Venue/Country: Online, U.S.A

    Updated: 2018-04-23 21:01:27 (GMT+9)

    Call For Papers - CFP

    Live Webinar Understanding and Implementing a Quality by Design Program

    Time: 01:00 PM EDT | 10:00 AM PDT | 12:00 PM CDT Duration 60 Minute

    Description

    This training will explain the main principles behind a QbD approach and provide guidelines in how to implement the concepts into a pharmaceutical development organization. Topics covered will include the target product quality profile, risk assessment, methods to establish a design space, and design of a control strategy. This review will help bridge the gap between understanding the principles and practical application.

    Why should you attend :

    The benefits of applying the QbD principles in the pharmaceutical industry have been well advertised. Most important are the direct benefits to our primary customer; the patient. Per Janet Woodcock M.D. Director, Center for Drug Evaluation and Research (CDER), Food and Drug Administration “All products are designed and developed to be of high quality; QbD provides a structured framework for developing, documenting and presenting development rationale, experience and knowledge of the formulation and the process, and to ensure manufacture of products consistently fit for patient use.” Application of these principles can also benefit the pharmaceutical companies by improving manufacturing efficiency and promoting innovation. However, implementing these principles into the pharmaceutical development culture can be challenging. QbD involves a complex set of interactions, technologies and systems that are not easy to grasp.

    Areas Covered

    • Quality Target Product Profile (QTPP)

    • Risk Assessment

    • Using Models

    • Design of Experiments

    • Developing a Design Space

    • Process Analytical Technology (PAT)

    • FMEA and Control Plan

    • Target Operational Profile

    • Control Strategy

    Who will Benefit

    This course is designed for people tasked with developing, filing, and manufacturing pharmaceutical products especially small molecule oral dosage forms. This includes individuals that have responsibilities for formulation development, scale-up, filing, and commercial manufacture of dosage forms as well as maintaining the high quality of those products. Following personnel will benefit from the course:

    • Senior quality managers

    • Quality professionals

    • Regulatory professionals

    • Compliance professionals

    • Production supervisors

    • Manufacturing engineers

    • Production engineers

    • Process owners

    • Quality engineers

    • Quality auditors

    • Development professionals

    • Senior development managers

    Speaker Profile

    Expertise: Over 25 years of technical leadership experience in product development, process development, technology transfer, and process optimization. Skilled in taking new products from early laboratory stage to successful manufacturing launch. Expert in integrating Quality by Design and risk management into product development. Experience in establishing a Quality System for a R&D Quality Assurance organization.

    Experience: Headed product development departments at Abbott Laboratories and AbbVie Inc. Leadership positions in numerous technical consortiums.

    Price: $179 One Dial-in One Attendee | Corporate Live Recorded $279 One Dial In - Max 10 attendees |Group $695 Multiple locations upto 5 dial in | Recorded $249


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.